Description
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
Purity | ≥70% |
---|---|
Formula | C14H10N2O4 |
Formula Wt. | 270.24 |
Chemical Name | 3,6-Dimethyl-1,8-diazaanthracene-2,7,9,10(1H,8H)-tetrone |
IUPAC Name | 3,7-dimethyl-1,9-dihydropyrido[3,2-g]quinoline-2,5,8,10-tetrone |
Appearance | Orange Solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Endogenous peptide hormone, involved in feeding...
Semi-synthetic taxane.
ABHD6 inhibitor.
Macrolide; threonyl-tRNA synthetase/ligase inhi...
Statin; HMG-CoA reductase inhibitor, potential ...
Iron chelator.
Sesquiterpene found in Curcuma.
May be useful against COVID-19
Inhibitor of PTEFb/CDK9.
Inhibitor of EGFR, HER2, and HER3.
Alcoholic β-glucoside found in willow bark, sa...
Calcium channel blocker.
COMT inhibitor.
Nitrogen mustard, DNA alkylator.
BTK inhibitor.
Mycotoxin that has structural similarity to est...
Cell membrane permeability modulator, topoisome...
PARP inhibitor; potential Pim1 inhibitor.
Thrombin inhibitor.
TGFbeta receptor inhibitor